glp-1 medication competitors pharmaceutical companies Agonists Market Report 2025-2033, By Product, Molecule, and Geo GLP-1 Receptor Agonist Market Size

doi: 10.1186/s10194-021-01337-0

Liraglutide suppresses non-esterified free fatty acids and soluble vascular cell adhesion molecule-1 compared with metformin in patients with recent-onset type 2 diabetes

But the science is moving fast, and the early signs suggest this possibility deserves serious, large-scale clinical trials

Recently Novo Nordisk announced the acquisition of INV-202, an oral CB1 inverse agonist designed to preferentially block CB1R in peripheral tissues

doi: 10.1038/sj.ijo.0801126

Keep a simple log of when you feel cold, what you're doing, and whether the sensation improves with warm clothing or a meal